Advanced search
Publication Cover
Clinical Epidemiology Volume 13, 2021 - Issue
Submit an article Journal homepage
107
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis

Noel S Weiss1 Department of Epidemiology, University of Washington, Seattle, WA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3987-5184View further author information
ORCID Icon,
Esther Perez Trejo2 School of Public Health, University of Montreal, Montreal, QC, CanadaView further author information
,
Richard Kronmal3 Department of Biostatistics, University of Washington, Seattle, WA, USAView further author information
,
Joao Lima4 Department of Medicine, Johns Hopkins University, Baltimore, MD, USAView further author information
&
Susan R Heckbert1 Department of Epidemiology, University of Washington, Seattle, WA, USAORCID Iconhttps://orcid.org/0000-0002-7100-512XView further author information
ORCID Icon
Pages 265-272 | Published online: 07 Apr 2021

References

  • Chugh SS, Blacksheer J, Shen WK, et al. Epidemiology and natural history of atrial fibrillation. J Am Coll Cardiol. 2001;37:371–378. doi:10.1016/S0735-1097(00)01107-411216949
  • Patton KK, Heckbert SR, Alonso A, et al. N-terminal pro-B-type natriuretic peptide as a predictor of incidence atrial fibrillation: the effects of age, sex, and ethnicity. Heart. 2013;99:1832–1836. doi:10.1136/heartjnl-2013-30472424131775
  • Svennberg E, Lindahl B, Berglund L, et al. NT-proBNP is a powerful predictor for incident atrial fibrillation – validation of a multimarker approach. Int J Cardiol. 2016;223:74–81. doi:10.1016/j.ijcard.2016.08.00127541645
  • Smith JG, Newton-Cheh C, Almgren P, et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. JACC. 2010;56:1712–1719. doi:10.1016/j.jacc.2010.05.04921070922
  • Schnabel RB, Wild PS, Wilde S, et al. Multiple biomarkers and atrial fibrillation in the general population. PLoS One. 2014;9:e112486. doi:10.1371/journal.pone.011248625401728
  • Sinner MF, Stepas KA, Moser CB, et al. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF consortium of community-based cohort studies. Eurospace. 2014;16:1426–1433. doi:10.1093/europace/euu175
  • Kaffer K, Geisel MH, Mohlenkamp S, et al. B-type natriuretic peptide for incident atrial fibrillation – the Heinz Nixdorf Recall Study. J Cardiol. 2015;65:453–458. doi:10.1016/j.jjcc.2014.08.00325241013
  • Kumarathurai P, Mouridsen MR, Mattson N, et al. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study. Eurospace. 2017;19:364–370.
  • Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871–881. doi:10.1093/aje/kwf11312397006
  • Chrispin J, Jain A, Soliman EZ, et al. Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA. JACC. 2014;63:2007–2013. doi:10.1016/j.jacc.2014.01.06624657688
  • Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111:1313–1320. doi:10.1161/01.CIR.0000157730.94423.4B15769774
  • Cooke G, Doust J, Sanders S. Is pulse palpation helpful in detecting atrial fibrillation? A systematic review. J Fam Pract. 2006;55:130–134.16451780
  • Fitzmaurice DA, Hobbs FDR, Jowett S, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 years or over: cluster randomized controlled trial. BMJ. 2007;335(7616):383. doi:10.1136/bmj.39280.660567.5517673732
  • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation. Ann Intern Med. 2007;146:857–867. doi:10.7326/0003-4819-146-12-200706190-0000717577005
  • Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of the new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet. 2014;383:955–962. doi:10.1016/S0140-6736(13)62343-024315724
  • Freedman B, Martinez C, Katholing C, et al. Residual risk of stroke and death in anticoagulant-treated patients with atrial fibrillation. JAMA Cardiol. 2016;1:366–368. doi:10.1001/jamacardio.2016.039327438123
  • Gudmundsdottir KK, Fredriksson T, Svennberg E, et al. Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the Strokestop II study. Europace. 2020;22:24–32. doi:10.1093/europace/euz25531790147
  • Kirchhof P, Benussi S, Kotechka D, et al. Guidelines for the management of atrial fibrillation. Eur Heart J. 2016;37:2893–2962.27567408

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.